In focus · trending topic

Anemia

10 stories · following the connections

FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXFeb 27, 2018, 9:11 PM UTC

FibroGen Reports Third Quarter 2017 Financial Results

By Nasdaq OMXNov 8, 2017, 9:02 PM UTC

About FibroGen, Inc.FibroGen to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

By Nasdaq OMXJun 13, 2017, 11:00 AM UTC

FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadustat in Anemia Associated With Lower Risk MDS

By Nasdaq OMXMar 31, 2017, 11:05 AM UTC

FibroGen to Report Third Quarter 2016 Financial Results on November 8, 2016

By Nasdaq OMXNov 1, 2016, 9:00 PM UTC

FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China

By Nasdaq OMXOct 31, 2016, 12:01 PM UTC

FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China

By Nasdaq OMXOct 31, 2016, 12:01 PM UTC

FibroGen Announces Fiscal 2015 Financial Results

By Nasdaq OMXFeb 29, 2016, 9:02 PM UTC